Health
First person with MS to play in the NBA shares his inspiring message: 'Make the most of it'
Multiple sclerosis is a life-changing diagnosis for one million people who are affected in the U.S. — but for a professional athlete, its physical limitations can seem particularly challenging.
Chris Wright, 34, the first person with MS to play in the National Basketball Association (NBA), has been living with the disorder since his 2012 diagnosis.
For World MS Day on May 30, Wright and his neurologist, Dr. Heidi Crayton, joined Fox News Digital in an on-camera interview from Washington, D.C., to discuss how he’s come to terms with his MS and to share words of wisdom for others facing the diagnosis. (See the video at the top of this article.)
DISRUPTED SLEEP, PLUS NIGHTMARES COULD BE LINKED TO AUTOIMMUNE DISEASES, EXPERTS SAY
Wright first experienced symptoms in 2012, he said, when he noticed tingling in his right foot while warming up for an overseas basketball game in Turkey.
“As I was shooting, I felt a tingling sensation in my right hand that eventually spread throughout my entire body within a matter of a minute,” he told Fox News Digital.
Chris Wright, 34, the first person with MS to play in the NBA, has been living with the disorder since his 2012 diagnosis. (Getty Images/Chris Wright)
His coaches sent him to a doctor, who told him to take the day off.
“The next morning I woke up, and I couldn’t walk. I couldn’t stand up. I couldn’t really use my limbs,” he recalled.
‘LIQUID GOLD’ COULD BRING NEW HOPE TO MULTIPLE SCLEROSIS PATIENTS, STUDY SUGGESTS: ‘PROFOUND BENEFIT’
Wright returned to the doctor, this time in a wheelchair.
“They sent me to a specialist, where I was quickly diagnosed with multiple sclerosis.”
MS is a chronic disease of the central nervous system that can affect movement, vision, speech and other functions.
After going through several other doctors, Wright found Dr. Crayton, a board-certified neurologist who practices at the Multiple Sclerosis Center of Greater Washington.
Chris Wright of Bertram Derthona Basket Tortona in action during the LBA Lega Basket Series A Playoffs Semi-Final Game 3 match between Bertram Derthona Basket Tortona and Virtus Segafredo Bologna PalaEnergica Paolo Ferraris on May 31, 2022, in Casale Monferrato, Italy. (Getty Images)
“What led me to her was her confidence and her ability to simplify what it meant to have MS and to make it manageable for me. [She] helped me understand that I could still go on with my career and my life in a way that I wanted to,” he said.
Crayton noted that the patient-doctor relationship is a “marathon, not a sprint.”
She told Fox News Digital, “It’s really important to find a doctor they can trust, who they can communicate with, who they can partner with to make decisions.”
TEENAGER IS PRIMARY CAREGIVER FOR NEW MEXICO MOM WITH MS: ‘WE’RE A TEAM’
“You need a team of people who support you, love you and accept you.”
Less than a year after his diagnosis, Wright became the first person with MS to play in the NBA when he signed with the Dallas Mavericks.
“MS impacted my career tremendously, because there was nobody before me,” Wright told Fox News Digital.
“You need a team of people who support you, love you and accept you.”
“I had NBA offers that were retracted because of the possibility of me having medical conditions and just being in uncharted territory — but I kept working and overcame it.”
BREAKTHROUGH FOR MULTIPLE SCLEROSIS SUFFERERS MAY INVOLVE HELPFUL HORMONE: ‘PATIENTS SHOULD REMAIN OPTIMISTIC’
Wright, a husband and father of three, is no longer playing basketball these days, but he is feeling healthy and enjoying life, he said.
“Living with MS, it looks good, it feels good — I feel great,” he said.
“I try to stay active. I try to stay healthy. I try to stay moving. And I’ve been able to keep myself healthy and continue to be a father and live my life the way I want to live.”
‘Badge of honor’
For all those facing a new diagnosis, Wright encouraged seeking out resources from people who have “walked these halls” before.
“There are people who understand what you’re going through, and it’s important to hear other stories and get a foundational knowledge of what your life will look like moving forward.”
After going through several other doctors, Wright found Dr. Crayton, pictured here, a board-certified neurologist who practices at the Multiple Sclerosis Center of Greater Washington. (Dr. Heidi Crayton)
Wright is involved with Express4MS, a campaign that encourages people with MS to express themselves, share their stories and discuss treatment options with their doctors.
“It’s just something you can put in your toolbox to find information, inspiration and motivation to live every day in a positive way,” Wright said.
“Walk with pride, and know that you’re going to be OK.”
“I would say to people: Stay with it, go through those tough times, figure out what works for you,” he said.
“Figure out how you can be successful at whatever it is you do.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Wright urges MS patients to look at the disease not as a hindrance, but as a “badge of honor.”
He said, “Walk with pride, and know that you’re going to be OK.”
Clayton advises her MS patients to “treat your body like a temple.”
Chris Wright of Bertram Derthona Basket Tortona in action during the LBA Lega Basket Serie A Playoffs Semi-Final Game 3 match between Bertram Derthona Basket Tortona and Virtus Segafredo Bologna PalaEnergica Paolo Ferraris on May 31, 2022, in Casale Monferrato, Italy. (Getty Images)
“It will pay you back in spades if you can invest in your health — eat well, exercise, sleep,” she said.
While people with MS will always have bad days, Wright is focused on maintaining a positive outlook.
“As long as you’re above ground, you have an opportunity to make the most of it,” he said.
“Every action has an equal and opposite reaction — so whatever you put out there is the energy that’s going to come back.”
For more Health articles, visit www.foxnews.com/health.
Just For You
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
NEWYou can now listen to Fox News articles!
The leading causes of death have changed dramatically since America’s founding 250 years ago, highlighting how far medicine has come.
Diseases that once devastated communities have largely given way to chronic conditions, data shows, reflecting centuries of breakthroughs in public health, prevention and treatment.
“The amount of changes that have happened over the past 250 years are immeasurable when it comes to life expectancy and disease,” Kenneth J. Perry, M.D., an emergency physician in Charleston, South Carolina, told Fox News Digital.
5 OF AMERICA’S GREATEST MEDICAL BREAKTHROUGHS REVEALED AS THE NATION MARKS 250 YEARS
“Our life expectancy as a country increased from roughly 30 years at the time of the country’s founding to close to 80 years today.”
Check out the following details.
An illustration of an 18th century hospital. The leading causes of death have changed dramatically since America’s founding 250 years ago. (Hulton Archive/Getty Images)
What killed Americans in 1776?
Although there were no official national mortality records in 1776, historians agree that the following illnesses were responsible for the largest number of deaths.
- Smallpox: This viral disease, which causes fever and a blistering rash, had about a 30% fatality rate before the first vaccine became available in 1796. Historians estimate the North American epidemic killed at least 100,000 to 130,000 people over several years.
- Tuberculosis: Also known as consumption, this bacterial infection primarily attacks the lungs. It was one of the leading chronic causes of adult death in the colonies, according to the National Library of Medicine (NLM).
- Pneumonia: A lung infection that fills air sacs with fluid or pus, pneumonia was frequently fatal in 1776 because no antibiotics or effective treatments existed, per the National Institutes of Health (NIH).
- Dysentery and diarrheal diseases: Intestinal infections, which caused severe diarrhea and dehydration, were common in 1776 because of poor sanitation and contaminated food and water, especially in military camps, per NIH and NLM.
- Malaria: This mosquito-borne parasitic disease causes recurrent fever and chills. It was endemic throughout much of the Southern colonies, the CDC states.
- Yellow fever: A mosquito-borne viral disease, yellow fever can cause liver failure and bleeding. Periodic epidemics struck colonial port cities in the late 1700s, NLM records show.
- Typhoid fever: This bacterial infection spreads through contaminated food and water. Recurring outbreaks were common in places where sanitation was poor, historians confirm.
- Childbirth complications: Maternal deaths from hemorrhage, infection or obstructed labor were common in 1776. This was a major cause of death among women of childbearing age, the NLM states.
- Wound infections: In colonial times, cuts or injuries often led to bacterial infections. These could prove fatal because antisepsis therapies, germ theory and antibiotics did not yet exist.
- Infant mortality: It was extremely common for children to die before age 1, with roughly 10% to 30% of infants not living to their first birthday in many colonial communities, historical records show.
These conditions had much higher fatality rates in 1776 because Americans had no antibiotics, few vaccines, no understanding of germ theory, no sterile surgical techniques and limited access to hospitals, experts note.
Yellow fever epidemic in Philadelphia, 1793. Carriages rumbled through the streets to pick up the dying and the dead. (Getty Images)
There was also a lack of safe drinking water, modern sewage systems and refrigeration — making it more likely for foodborne and waterborne illnesses to spread.
Patients also did not yet have access to blood transfusions, anesthesia and other lifesaving medical advances, according to the CDC, NLM and NIH.
Common causes of death in the 1900s
The first official national mortality statistics were published by the U.S. Census Bureau in 1900.
The data points to the following leading causes of death in the 1900s.
- Influenza & pneumonia: Viral flu and bacterial/viral lung infections were responsible for about 40,000 to 65,000 deaths per year during the period between 1900 and 1910, according to the CDC’s National Center for Health Statistics (NCHS).
- Tuberculosis: The bacteria lung infection claimed about 35,000 to 40,000 lives per year during that same time frame, per the above source.
- Diarrhea/enteritis: Intestinal infections causing severe dehydration led to approximately 25,000 to 35,000 annual deaths between 1900 and 1910.
- Heart disease: Diseases affecting the heart and circulatory system killed between 27,000 and 40,000 Americans per year in this time frame, according to NCHS.
- Stroke: Strokes, which interrupt the flow of blood to the brain, took between 20,000 and 30,000 lives annually.
- Kidney disease: Diseases that impair kidney function (also called nephritis), killed between 17,000 and 25,000 people in the U.S. each year, data shows.
- Accidents: Between 15,000 and 22,000 Americans died each year from unintentional injuries at work, home and in transportation, per NCHS.
- Cancer: Various types of cancer, in which malignant tumors invade surrounding tissues, contributed to between 13,000 and 20,000 deaths annually in this time frame.
- Senility: This was a historical diagnosis for deaths attributed to old age in the early 1900s. It was listed as the cause of death for about 12,000 to 18,000 people per year.
- Diphtheria: The bacterial throat infection, which can block the airway, led to 8,000 to 12,000 deaths per year, mortality data highlights.
Nearly one-third of all deaths were caused by pneumonia, tuberculosis and diarrheal diseases, and about 30% of all deaths occurred in children younger than age 5, records show.
A diphtheria vaccination is administered in the 1900s in this illustration. (Getty Images)
Medical breakthroughs that transformed survival
The introduction of vaccines dramatically reduced certain diseases, including smallpox, polio, diphtheria, measles and whooping cough.
In 1980, smallpox became the first human disease ever eradicated worldwide.
The introduction of vaccines dramatically reduced certain diseases, including smallpox, polio, diphtheria, measles and whooping cough. (iStock)
Improvements in clean water and sanitation also contributed to greater longevity, as cities built sewage systems, water treatment plants and indoor plumbing, according to the CDC. As a result, deaths from cholera, dysentery and typhoid fever fell dramatically.
Germ theory also emerged in the late 1800s, in which scientists discovered that germs caused disease. This led to vast transformations in surgery, childbirth, handwashing, sterilization and infection control, per NIH and the Science History Institute.
In the 1940s, the widespread use of penicillin allowed for the treatment of diseases that were once fatal.
Routine screening has enabled earlier detection of breast, cervical and colorectal cancers, while improvements in surgery, radiation therapy, chemotherapy, targeted therapies and immunotherapy have helped many patients live longer.
A recent analysis by the National Cancer Institute found that prevention and screening accounted for about 80% of the cancer deaths averted over the past 45 years for five major cancer types.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
In the 1940s, the widespread use of penicillin allowed for the treatment of diseases that were once fatal, including pneumonia, strep infections, wound infections and sepsis.
Advances in childbirth — including prenatal care, Cesarean sections, blood transfusions, antibiotics and neonatal intensive care — also dramatically improved maternal and infant survival compared with colonial America.
The use of CPR, defibrillators, coronary care units, bypass surgery, stents, statins and blood pressure medications helped to reduce cardiovascular deaths. (iStock)
The mid-20th century also ushered in improvements in heart disease treatments. The use of CPR, defibrillators, coronary care units, bypass surgery, stents, statins and blood pressure medications helped to reduce cardiovascular deaths, according to the American Heart Association.
What’s killing Americans today?
In a vast contrast to 1776, chronic diseases now account for most American deaths, because people generally live long enough to develop them.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Current U.S. health data indicates that the following conditions are now the leading causes of death.
- Heart disease: Disorders affecting the heart and blood vessels, including coronary artery disease and heart attacks, killed more than 638,000 Americans in 2024, according to NCHS data.
- Cancer: Approximately 619,876 people died of cancer in the U.S. in 2024.
- Unintentional injuries: Accidental deaths, including drug overdoses, motor vehicle crashes and falls, were the causes of more than 197,440 deaths that same year, records show.
- Stroke: Interruption of blood flow to the brain, which causes brain damage, claimed 166,852 American lives in 2024, per NCHS.
- Chronic lower respiratory disease: Long-term lung diseases — such as COPD, emphysema and chronic bronchitis — killed 145,643 people in the U.S. that year.
- Alzheimer’s disease: The most common type of dementia, which destroys memory and cognitive function, was responsible for 116,022 deaths in 2024, NCHS data shows.
- Diabetes: The chronic disease, which impairs the body’s ability to properly regulate blood sugar, contributed to 94,445 deaths that year.
- Kidney disease: Diseases that damage the kidneys and impair their ability to filter blood were blamed for 55,081 deaths in 2024.
- Chronic liver disease/cirrhosis: Progressive liver damage caused by conditions such as hepatitis, alcohol misuse or fatty liver disease were responsible for 52,274 deaths that year, per NCHS.
- Suicide: Death caused by intentional self-harm claimed 48,824 lives in 2024. (If you or someone you know is having thoughts of suicide, please contact the National Suicide Prevention Lifeline at 1-800-273-TALK (8255).)
CLICK HERE FOR MORE HEALTH STORIES
“The transformation of deaths in the last 250 years, largely from infectious diseases to currently chronic debilitating diseases, represents both success and new challenges Americans will have to face,” Dr. Omer Awan, a physician and professor at the University of Maryland School of Medicine, told Fox News Digital.
“The chronic disease epidemic has been fueled by a lack of exercise, as well as by diets rich in fats, salts and ultraprocessed foods,” a doctor told Fox News Digital. (iStock)
The uptick in chronic diseases is driven not only by an increasingly aging population, but by people’s lifestyle behaviors, according to the doctor.
“The chronic disease epidemic has been fueled by lack of exercise, as well as diets rich in fats, salts and ultraprocessed foods,” he told Fox News Digital. “This has also led to the rise of obesity, which contributes to many of the chronic medical conditions that are among the top killers for Americans in the modern era.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Public health advances can change the course of health for millions of Americans, Awan said.
“Just as vaccines and antibiotics prolonged life centuries ago, so can lifestyle changes, exercise and new therapies that target obesity — like GLP-1 drugs and medications that promote better metabolic health.”
Novo Nordisk to slash Wegovy, Ozempic list prices
Board certified rheumatologist Dr. Mahsa Tehrani discusses Novo Nordisk’s decision to dramatically cut the U.S. list prices for its popular diabetes and weight-loss drugs Ozempic and Wegovy on ‘America Reports.’
NEWYou can now listen to Fox News articles!
Millions of Medicare beneficiaries struggling with obesity could soon see the cost of weight-loss drugs plummet, as a new federal pilot program launching July 1 expands access to GLP-1 medications like Wegovy and Zepbound for eligible seniors.
Through a new trial called Medicare GLP-1 Bridge, the federal government is now offering a selection of the brand-name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month, The Associated Press reported.
The covered medications include drugmaker Eli Lilly’s Foundayo tablets and Zepbound KwikPens and Novo Nordisk’s Wegovy injections and tablets, all of which have been FDA-approved for weight loss, according to the report.
OZEMPIC USERS MAY BE MAKING A MAJOR WEIGHT-LOSS MISTAKE, NEW STUDY SUGGESTS
The temporary program is set to run until the end of 2027.
This is the first time GLP-1s (glucagon-like peptide-1 receptor agonists) will be covered by insurance when used solely for weight loss.
A new federal pilot program launching July 1 expands access to GLP-1 medications like Wegovy and Zepbound for eligible seniors. (iStock)
Prior to this new Medicare pilot, seniors who wanted to access GLP-1s for obesity alone paid about $1,350-$1,650 per month for Novo Nordisk’s Wegovy (semaglutide) and about $1,086 monthly for Lilly’s Zepbound (tirzepatide). However, both manufacturers offered some cash-pay options that significantly reduced those prices for eligible patients.
GLP-1 WEIGHT LOSS DRUGS ARE RESHAPING THE BRIDAL INDUSTRY AS SHOPS RUSH ORDERS AND REQUIRE NEW WAIVERS
There are some parameters surrounding the coverage — older adults must have had a body mass index (BMI) of 35 or higher when they started GLP-1 therapy, or a BMI of 27 or higher alongside another health condition, such as a past heart attack or stroke or prediabetes.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Those who already have insurance coverage for other diseases, such as diabetes and sleep apnea, are not eligible for the program.
Through a new trial called Medicare GLP-1 Bridge, the federal government is now offering a selection of the brand-name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month. (iStock)
There are more than 70 million Americans currently enrolled in Medicare, 10 million of whom are overweight or obese, according to Juliette Cubanski, vice president and director of the program on Medicare policy at the healthcare research nonprofit KFF.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“For many older Americans living with obesity, this is a moment they and their families have been waiting for,” Jamey Millar, Novo Nordisk’s executive vice president of U.S. operations, said in a press release.
“The Medicare GLP-1 Bridge program offers a new, affordable path to an FDA-approved treatment that was previously not covered.”
CLICK HERE FOR MORE HEALTH STORIES
Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, said he hopes the program can help his agency collect data to potentially work toward longer-term coverage, while providing immediate relief to cash-strapped older Americans, AP reported.
“The sheer cost of these medications is a huge barrier to access,” he said in a call with reporters. “That ends today.”
Prior to this new Medicare pilot, seniors who wanted to access GLP-1s for obesity alone paid about $1,350-$1,650 per month for Novo Nordisk’s Wegovy (semaglutide) and about $1,086 monthly for Lilly’s Zepbound (tirzepatide). (iStock)
Oz told reporters that CMS plans to “carefully track participation and outcomes” to see whether an extension of the Bridge program or another solution is the best way to move forward. He told AP a federal law permanently allowing the coverage is “not essential right now” but something “for Congress to debate amongst themselves.”
“We can’t decide what’s going to happen long term with Bridge until we see some of the data,” he said, adding that there are ongoing talks with drug companies to lower costs.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
One potential concern is that older patients tend to have more adverse effects to medication in general , according to Dr. Micah Eimer, a clinical assistant professor of cardiology at the Northwestern University Feinberg School of Medicine.
“Specifically, in our research, older patients on blood pressure medications were more likely to experience hypotensive side effects, such as fainting and dizziness, after starting a GLP-1,” he said in a statement.
The Associated Press contributed to this report.
-
Health13 minutes agoIs Skipping Breakfast Bad? The Weight-Loss Truth May Surprise You
-
Lifestyle28 minutes agoNearly half of Americans surveyed don’t know what America 250 commemorates
-
Technology38 minutes agoAmazon updated 2023’s Fire HD 10 tablet with 4GB of RAM
-
World43 minutes agoInterpol issues red notice for Ukrainian woman wanted for Monaco apartment bombing targeting oligarch
-
Politics50 minutes agoMamdani blasts ICE agents, Elon Musk and ‘supremacy’ in America 250 speech ahead of July 4 weekend
-
Health53 minutes agoWhat killed Americans in 1776? The answer is dramatically different from today
-
Sports58 minutes agoKnicks champion says he hopes ‘truth comes out’ after leaving team for Eastern Conference rival
-
Technology1 hour agoCheap streaming box could hijack your home internet
